0001654954-22-001174.txt : 20220204 0001654954-22-001174.hdr.sgml : 20220204 20220204193847 ACCESSION NUMBER: 0001654954-22-001174 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220202 FILED AS OF DATE: 20220204 DATE AS OF CHANGE: 20220204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mazar Andrew Paul CENTRAL INDEX KEY: 0001727393 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 22595189 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD STREET 2: SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320463781 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 BUSINESS PHONE: 8473880349 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2022-02-02 false 0001645469 Monopar Therapeutics MNPR 0001727393 Mazar Andrew Paul 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 true true false Chief Scientific Officer Stock Options 2.80 2022-02-02 4 A false 88874 0 A 2032-02-01 Common Stock 88874 88874 D Restricted Stock Units 0 2022-02-02 4 A false 67251 0 A Common Stock 67251 90398 D Options vest 6/48ths on June 30, 2022 and 1/48ths per month thereafter. RSUs vest 6/48ths on June 30, 2022 and 3/48ths per quarter thereafter (September 30, 2022, December 31, 2022, March 31, 2023, June 30, 2023, September 30, 2023, December 31, 2023, March 31, 2024, June 30, 2024, September 30, 2024, December 31, 2024, March 31, 2025, June 30, 2025, September 30, 2025, December 31, 2025) /s/ Kim R. Tsuchimoto, Attorney-in-fact 2022-02-04